News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Weisman Wayne
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/19/2023 |
4
| Weisman Wayne (Director) has filed a Form 4 on Societal CDMO, Inc.
Txns:
| Granted 73,620 shares
@ $0 Granted 27,229 options to buy
@ $0.74, valued at
$20.1k
|
|
08/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/19/2021 |
4
| Weisman Wayne (Director) has filed a Form 4 on ReWalk Robotics Ltd.
Txns:
| Sold 4,129 shares
@ $1.53, valued at
$6.3k
|
|
05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/11/2020 |
4
| Weisman Wayne (Director) has filed a Form 4 on Recro Pharma, Inc.
Txns:
| Granted 8,363 shares
@ $0 Granted 12,405 options to buy
@ $8.37, valued at
$103.8k
|
|
05/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/27/2020 |
4
| Weisman Wayne (Director) has filed a Form 4 on Baudax Bio, Inc.
Txns:
| Bought 10,000 shares
@ $2.29, valued at
$22.9k
|
|
12/09/2019 |
4
| Weisman Wayne (Director) has filed a Form 4 on Recro Pharma, Inc.
Txns:
| Granted 15,284 shares
@ $0 |
|
12/09/2019 |
4
| Weisman Wayne (Director) has filed a Form 4 on Baudax Bio, Inc.
Txns:
| Granted 20,000 shares
@ $0 |
|
05/10/2019 |
4
| Weisman Wayne (Director) has filed a Form 4 on Recro Pharma, Inc.
Txns:
| Granted 7,955 shares
@ $0 Granted 10,888 options to buy
@ $8.8, valued at
$95.8k
|
|
03/28/2019 |
4
| Weisman Wayne (Director) has filed a Form 4 on ReWalk Robotics Ltd.
Txns:
| Granted 116,496 shares
@ $0 |
|
05/14/2018 |
4
| Weisman Wayne (Director) has filed a Form 4 on Recro Pharma, Inc.
Txns:
| Exercised 13,274 restricted stock units
@ $0 |
|
05/08/2018 |
4
| Weisman Wayne (Director) has filed a Form 4 on Recro Pharma, Inc.
Txns:
| Granted 6,183 shares
@ $0 Granted 5,742 options to buy
@ $11.32, valued at
$65k
|
|
05/02/2018 |
4
| Weisman Wayne (10% Owner) has filed a Form 4 on ReWalk Robotics Ltd.
Txns:
| Granted 22,727 shares
@ $0 |
|
06/29/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/19/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/26/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/25/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/23/2016 |
4
| Weisman Wayne (Director) has filed a Form 4 on Recro Pharma, Inc.
Txns:
| Sold 11,082 shares
@ $9.0009, valued at
$99.7k
Sold 3,702 shares
@ $9.0009, valued at
$33.3k
Sold 2,068 shares
@ $9.006, valued at
$18.6k
Sold 691 shares
@ $9.006, valued at
$6.2k
Sold 4,648 shares
@ $9, valued at
$41.8k
Sold 1,553 shares
@ $9, valued at
$14k
Sold 6,737 shares
@ $9.0009, valued at
$60.6k
Sold 2,250 shares
@ $9.0009, valued at
$20.3k
Sold 450 shares
@ $9, valued at
$4.1k
Sold 150 shares
@ $9, valued at
$1.4k
Sold 3,748 shares
@ $6.4559, valued at
$24.2k
|
|
03/09/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|